A bill for an act relating to manufacturers and distributors of 340B drugs.
SF 2312 clarifies Iowa's rules for manufacturers and distributors of 340B drugs, which are medications sold at discounted prices under a federal program. The bill defines key terms like "340B drug" (a federally discounted drug purchased by safety-net health facilities) and prohibits manufacturers or distributors from interfering with a covered entity’s acquisition of these drugs or their delivery to contract pharmacies. This directly affects drug manufacturers and wholesale distributors operating in Iowa, requiring them to allow normal access to 340B drugs unless federal health officials prohibit it. The law aims to ensure consistent access to discounted medications for clinics and hospitals serving low-income patients.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 12, 2026
Last action Feb 18, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
1
Committee
1
Feb 18, 2026
Upper · Passed
Subcommittee: Sweeney, Knox, and Warme.
upper
Feb 12, 2026
Introduced
Introduced, referred to Commerce.
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Annette Sweeney
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SF 2312
Scope: IA
Hi! I can help you understand SF 2312. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline